PROCTER & GAMBLE HEALTH
|
The Current P/B Ratio of PROCTER & GAMBLE HEALTH is 19.58.
| Share Price | ₹6,187.7 | Jun 11,2026 |
| Market Cap | ₹10,271.6 Cr | |
| Book Value | ₹524.6 Cr | Mar2026 - Standalone Results |
| Price/Book | 19.58x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of PROCTER & GAMBLE HEALTH
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹10,271.6 Cr] as on Jun 11,2026
(/) Book Value [ ₹524.6 Cr] based on Mar2026 - Standalone Results
(=) P/B Ratio [ 19.58x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '19.58 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/B Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PB (Price/Book ) ratio chart of PROCTER & GAMBLE HEALTH
PB Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/b ratio for fiscal years ending Mar2025 to Jun2022 averaged 13.95x.
- PROCTER & GAMBLE HEALTH 's operated at median p/b ratio of 14.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/b ratio peaked in Mar2025 at 16.04x.
- PROCTER & GAMBLE HEALTH 's p/b ratio hit its five-year low in Jun2022 of 11.41x.
How does PROCTER & GAMBLE HEALTH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| PROCTER & GAMBLE HEALTH | 524.55 | 19.58 | 10,271.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.15 | 430,513.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 10.53 | 176,570.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 18.44 | 154,670.0 |
| CIPLA LTD | 34,369.40 | 3.25 | 111,725.0 |
| DR REDDYS LABORATORIES LTD | 37,891.50 | 2.81 | 106,424.0 |
| MANKIND PHARMA LTD | 16,300.30 | 6.01 | 97,948.2 |
| LUPIN LTD | 22,448.30 | 4.63 | 103,975.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.10 | 111,254.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.22 | 84,241.1 |
| LAURUS LABS LTD | 5,275.08 | 14.24 | 75,121.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PROCTER & GAMBLE HEALTH 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.22x |
| Max industry PB | 19.58x |
| Median industry PB | 5.15x |
| Average industry PB | 8.27x |
You may also like the below Video Courses